Lyrica (Pregabalin) Tablets: Medical Uses, Side Effects and Safety Information

 Lyrica is the brand name for pregabalin, a prescription medicine that occupies an unusual position in modern pharmacology. It is approved for nerve pain, epilepsy, and anxiety, yet its exact mechanism remains only partly understood. It is widely prescribed across Denmark and the UK, but it is also a controlled substance with a recognised potential for misuse.

For anyone prescribed Lyrica—or considering it—the useful questions are straightforward: what does it actually treat, how well does it work, and what should you watch for? This article answers those questions with reference to European regulatory guidance and UK safety advice.

What Lyrica Is Approved to Treat

Pregabalin is authorised in the European Union for three distinct adult conditions: peripheral and central neuropathic pain, adjunctive therapy for partial seizures, and generalised anxiety disorder . The Danish Medicines Agency similarly recognises pregabalin as an option for neuropathic pain and, off-label, for short-term anxiety symptoms .

The neuropathic pain indication covers nerve damage from diabetes, shingles, or spinal cord injury. In the European Medicines Agency's assessment, 35% of patients with peripheral neuropathic pain achieved at least a 50% reduction in pain scores on pregabalin, compared with 18% on placebo. For central neuropathic pain, the figures were 22% versus 8% . These are meaningful differences, though they also show that most patients do not get complete relief.

For epilepsy, Lyrica is not a standalone treatment. It is added to existing medication for patients whose partial seizures are not controlled. In trials, roughly 45% of patients on 600 mg daily and 35% on 300 mg daily saw seizure reductions of 50% or more, against about 10% on placebo .

How Pregabalin Works and How It Is Taken

Pregabalin is structurally related to GABA, a calming neurotransmitter, but it does not act like a benzodiazepine. Its therapeutic effect is thought to come from binding to calcium channels in the nervous system, which reduces the release of excitatory neurotransmitters involved in pain, seizures, and anxiety . The full picture is still not settled, which is part of why pregabalin behaves differently from older drugs in its class.

Dosing starts at 150 mg per day, split into two or three doses. After three to seven days, the dose can rise to 300 mg daily, with further increases up to a maximum of 600 mg per day . Danish guidance for anxiety suggests a similar titration, starting at 150 mg daily and increasing weekly if needed . Patients with kidney problems need lower doses, and stopping treatment should be gradual, over at least a week .

Lyrica comes as hard capsules and an oral solution. The capsules contain lactose, which matters for anyone with galactose intolerance .

Side Effects: Dizziness, Drowsiness, and Euphoria

The most common side effects are dizziness and somnolence, each affecting more than one in ten patients . These are not trivial for everyday life. Danish authorities note that pregabalin carries a traffic safety risk and recommend a temporary driving ban when treatment starts . Alcohol amplifies the sedative effect .

A systematic review of gabapentinoids in neuropathic pain found that pregabalin was associated with more reported adverse effects than gabapentin, and that euphoria was reported in six pregabalin studies—a side effect not reported with gabapentin. The review authors identified this as the one effect that may correlate with addictive potential .

That brings up a risk that deserves direct mention. Pregabalin can be misused. The Danish Health Authority advises that the risk is greatest in people with an ongoing substance misuse problem, particularly opioid misuse . The UK has classified pregabalin as a controlled drug, reflecting this concern.

Pregnancy and Other Important Cautions

The safety advice around pregabalin in pregnancy has changed in recent years, and it is worth understanding clearly.

A large Nordic observational study of more than 2,700 pregnancies exposed to pregabalin in the first trimester found a slightly increased prevalence of major congenital malformations: about 6 in 100 exposed babies, compared with 4 in 100 in the unexposed comparison group . The MHRA reviewed this study and concluded that pregabalin may cause a small increase in risk. The product information now advises that effective contraception should be used during treatment and that Lyrica should be avoided in pregnancy unless clearly necessary .

For patients with epilepsy, the warning is particularly firm: do not stop pregabalin suddenly. Uncontrolled seizures can harm both the patient and an unborn baby .

Beyond pregnancy, Lyrica requires caution in older or frail patients, who face a higher risk of falls and serious events . The MHRA also advises folic acid supplementation for anyone planning a pregnancy while on antiepileptic treatment .

What Lyrica Offers—and What It Does Not

Lyrica is a legitimate treatment for three difficult conditions. For some patients with nerve pain, it takes the edge off a persistent, exhausting symptom. For some with partial seizures, it adds another layer of control when existing medication is not enough. For generalised anxiety, it has demonstrated effectiveness in trials, though its use for short-term anxiety in Danish general practice is off-label and requires an informed discussion with the patient .

It is not a cure, and it is not risk-free. Dizziness and drowsiness are common, the pregnancy signal is real, and the potential for misuse means it belongs in the same careful category as other medicines that affect the central nervous system. The practical takeaway for adults in Denmark and the UK is to treat Lyrica tablets as what they are: a useful prescription tool that works best when taken exactly as directed, reviewed regularly, and never adjusted without medical advice.